The higher expression of IFITM3 at time of relapse and the genetic loss-of-function data suggested a potential dependency of AML cells on IFITM3, wherein loss of IFITM3 caused decreased fitness in all AML cell lines tested. Here, IFITM3 is linked to acute myeloid leukemia.